New depression pill SP-624 enters Mid-Stage trial
NCT ID NCT06254612
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests whether a daily oral drug called SP-624 can safely reduce depression symptoms in adults with major depressive disorder. About 456 participants will receive either SP-624 or a placebo for several weeks. The main goal is to see if SP-624 leads to a greater improvement in depression scores compared to placebo.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- SP-624 (a drug taken as a daily capsule)
- What this could lead to
- If successful, this could lead to a new oral medication option for people with major depressive disorder.
- What could go wrong
- This is a mid-stage (Phase 2) trial, so results are still uncertain. The drug may not prove more effective than placebo, and side effects are still being studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Accel Clinical
Lakeland, Florida, 33803, United States
-
Accelerated Enrollment Solutions
Atlanta, Georgia, 30328, United States
-
Alivation Research
Lincoln, Nebraska, 68526, United States
-
Boston Clinical Trials
Boston, Massachusetts, 02131, United States
-
CenExel HRI
Marlton, New Jersey, 08053, United States
-
Center for Emotional Fitness
Cherry Hill, New Jersey, 08002, United States
-
CiTrials
Riverside, California, 92506, United States
-
Clinical Innovations
Bellflower, California, 90706, United States
-
Clinical Neuroscience Solutions
Jacksonville, Florida, 32256, United States
-
Clinical Neuroscience Solutions
Orlando, Florida, 32801, United States
-
Clinical Neuroscience Solutions
Memphis, Tennessee, 38119, United States
-
Coastal Carolina Research Center
North Charleston, South Carolina, 29405, United States
-
Collaborative Neuroscience Research
Torrance, California, 90504, United States
-
Core Clinical Research
Everett, Washington, 98201, United States
-
DMI Research
Pinellas Park, Florida, 33782, United States
-
Donald J. Garcia, Jr, MD, PA
Austin, Texas, 78737, United States
-
Excell Research
Oceanside, California, 92056, United States
-
Future Search Trials of Dallas
Dallas, Texas, 75231, United States
-
Grayline Research Center
Wichita Falls, Texas, 76309, United States
-
Haracec Clinical Research
El Paso, Texas, 79902, United States
-
IMA Clinical Research
Phoenix, Arizona, 85012, United States
-
IMA Clinical Research
Las Vegas, Nevada, 89102, United States
-
IMA Clinical Research
Albuquerque, New Mexico, 87109, United States
-
Integrative Clinical Trials
Brooklyn, New York, 11229, United States
-
MCB Clinical Research Centers
Colorado Springs, Colorado, 80910, United States
-
Magnolia Clinical Research
Cary, North Carolina, 27511, United States
-
Midwest Clinical Research Center
Dayton, Ohio, 45417, United States
-
Midwest Research Group
Saint Charles, Missouri, 63304, United States
-
Neurobehavioral Medicine Group
Bloomfield Hills, Michigan, 48302, United States
-
New Hope Clinical Research
Charlotte, North Carolina, 28211, United States
-
Next Level Clinical Trials
West Covina, California, 91790, United States
-
Noble Clinical Research
Tucson, Arizona, 85704, United States
-
North Star Medical Research
Middleburg Heights, Ohio, 44130, United States
-
Northwest Clinical Research Center
Bellevue, Washington, 98007, United States
-
Pillar Clinical Research
Richardson, Texas, 75080, United States
-
Pioneer Clinical Research
New York, New York, 10016, United States
-
R and H Clinical Research
Stafford, Texas, 77477, United States
-
Redbird Research
Las Vegas, Nevada, 89119, United States
-
Revive Research Institute
Elgin, Illinois, 60123, United States
-
SanRo Clinical Research Group
Bryant, Arkansas, 72022, United States
-
Segal Trials
Lauderhill, Florida, 33319, United States
-
Segal Trials - Miami Lakes
Miami Lakes, Florida, 33016, United States
-
Summit Headlands
Portland, Oregon, 97210, United States
-
Sun Valley Research Center
Imperial, California, 92251, United States
-
Sunwise Clinical Research
Walnut Creek, California, 94596, United States
-
Synergy San Diego
Lemon Grove, California, 91945, United States
-
Tandem Clinical Research
Marrero, Louisiana, 70072, United States
-
UNC Chapel Hill
Chapel Hill, North Carolina, 27599, United States
-
Velocity Clinical Research
Meridian, Idaho, 83642, United States
-
Velocity Clinical Research
Beachwood, Ohio, 44122, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a structured care pathway ease teen depression?
- Can a nasal spray break through tough depression?
- Could a new drug offer hope for Treatment-Resistant depression?
- Targeting depression: can MRI-Guided brain zaps rewire key circuits?
- Can a psychedelic trip plus a gentle ear zap lift depression?
- Can a smart brain implant outsmart depression?